This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Fri May 24, 2013 4:33 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 2 posts ] 
Author Message
 Post subject: CNT1275
PostPosted: Mon Nov 14, 2005 5:49 am 
Offline
Getting to Know You...
User avatar

Joined: Sun Nov 13, 2005 4:00 pm
Posts: 15
Does anyone participate a clinical study with CNT 1275 (CENTOCOR). I´m patient from Czech republic and we are only free persons ivolved in this study in my MS centrum, where I´m cured. Please anybody, who has inspierence with this, answer me.

Can I recognize, that I use placebo?


Top
 Profile  
 
 Post subject:
PostPosted: Mon Nov 14, 2005 10:17 am 
Offline
Family Member
User avatar

Joined: Wed Jun 01, 2005 3:00 pm
Posts: 51
Not exactly your study (CNTO-1275), but, my wife is in ABT-874 study. It also targets IL-12. I.e., for a non-biologist like me, it seems like the same thing.

I heard many different theories on identifying placebo. However, I really don't believe them too much. I'll get to that later after I state why one should stay in the treatment no matter if one is on placebo.

In my opinion, having a chance at receiving a non-placebo treatment for part of the year for something in the forefront of research is better then being on the poorly effective approved treatments.

Furthermore, for many studies, if the treatment looks promising, pharma companies often allow participants to remain on the treatment open label (no placebo) until FDA approval. That means that if one completes a study in a promising drug, one can continue to receive this drug for years before it is approved.

For most diseases, this is not a great benefit. However, with MS, because the approved treatments are not that effective, this is a very important consideration. Receiving a placebo in the short run, may be better in the long run anyway.

But, getting back to placebo identification: There are two versions I heard.

The first, relates to injection site reactions. I.e., "if you are having reactions, it is the real thing." But, in my observation, this doesn't make sense. There are three streams in the first part of the ABT-874 study, (1)placebo every week, (2)placebo and ABT-874 back and forth every week, (3) ABT-874 every week. My wife gets reactions randomly. I.e., she can go a few weeks without reactions, then get two reactions in a row. So, this theory cannot be accurate in this case.

The other theory I heard is to pay attention to how fast the powder dissolves in liquid when one is preparing a shot. I.e., placebo would dissolve faster then the real thing. For us, they all dissolve about equally. So, there is nothing to compare to. Of course, if the theory is wrong and placebo and the real thing dissolve at the same rate, this won't be much help either.

-Gary


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 2 posts ] 

All times are UTC - 8 hours [ DST ]


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: